Puna Bio receives investment from Corteva Catalyst
Puna Bio, an Argentina-based agricultural technology company, has secured new funding led by Corteva (NYSE: CTVA) through its Corteva Catalyst platform. The company specializes in biological solutions using extremophile organisms for regenerative agriculture.
Puna Bio's non-GMO seed treatments, derived from ancient bacteria found in Argentina's La Puna desert, increase productivity by 10-15% in fertile soils and can revitalize degraded soils. Their products, Kunza and Kanzama, have been used on over 800,000 acres across three commercial seasons.
The investment will support product portfolio expansion and market entry into the United States, Brazil, and Paraguay. The funding round includes participation from existing investors At One Ventures, SP Ventures, SOSV, Builders VC, and new investor Dalus Capital.
Puna Bio, un'azienda argentina specializzata in tecnologia agricola, ha ottenuto nuovi finanziamenti guidati da Corteva (NYSE: CTVA) attraverso la piattaforma Corteva Catalyst. L'azienda si concentra su soluzioni biologiche basate su organismi estremofili per l'agricoltura rigenerativa.
I trattamenti per semi non OGM di Puna Bio, derivati da antichi batteri presenti nel deserto La Puna in Argentina, aumentano la produttività del 10-15% nei terreni fertili e possono rigenerare i suoli degradati. I loro prodotti, Kunza e Kanzama, sono stati utilizzati su oltre 800.000 acri in tre stagioni commerciali.
L'investimento sosterrà l'espansione del portafoglio prodotti e l'ingresso nei mercati degli Stati Uniti, Brasile e Paraguay. Il round di finanziamento vede la partecipazione degli investitori esistenti At One Ventures, SP Ventures, SOSV, Builders VC e del nuovo investitore Dalus Capital.
Puna Bio, una empresa argentina de tecnología agrícola, ha asegurado nuevos fondos liderados por Corteva (NYSE: CTVA) a través de su plataforma Corteva Catalyst. La compañía se especializa en soluciones biológicas usando organismos extremófilos para la agricultura regenerativa.
Los tratamientos de semillas no transgénicos de Puna Bio, derivados de bacterias ancestrales encontradas en el desierto La Puna de Argentina, aumentan la productividad entre un 10-15% en suelos fértiles y pueden revitalizar suelos degradados. Sus productos, Kunza y Kanzama, se han utilizado en más de 800,000 acres durante tres temporadas comerciales.
La inversión apoyará la expansión del portafolio de productos y la entrada al mercado en Estados Unidos, Brasil y Paraguay. La ronda de financiamiento incluye la participación de los inversores existentes At One Ventures, SP Ventures, SOSV, Builders VC y el nuevo inversor Dalus Capital.
Puna Bio는 아르헨티나에 본사를 둔 농업 기술 회사로, Corteva (NYSE: CTVA)가 운영하는 Corteva Catalyst 플랫폼을 통해 신규 자금을 확보했습니다. 이 회사는 극한 환경 미생물을 활용한 재생 농업용 생물학적 솔루션을 전문으로 합니다.
Puna Bio의 비유전자변형(GMO) 종자 처리제는 아르헨티나 라 푸나 사막에서 발견된 고대 박테리아에서 유래했으며, 비옥한 토양에서 생산성을 10-15% 향상시키고 황폐해진 토양을 회복시킬 수 있습니다. Kunza와 Kanzama라는 제품은 세 차례 상업 시즌 동안 80만 에이커 이상에 사용되었습니다.
이번 투자는 제품 포트폴리오 확장과 미국, 브라질, 파라과이 시장 진입을 지원할 예정입니다. 이번 투자 라운드에는 기존 투자자 At One Ventures, SP Ventures, SOSV, Builders VC와 신규 투자자 Dalus Capital이 참여했습니다.
Puna Bio, une entreprise argentine de technologie agricole, a obtenu un nouveau financement mené par Corteva (NYSE: CTVA) via sa plateforme Corteva Catalyst. La société est spécialisée dans les solutions biologiques utilisant des organismes extrémophiles pour l'agriculture régénérative.
Les traitements de semences non OGM de Puna Bio, dérivés de bactéries ancestrales trouvées dans le désert de La Puna en Argentine, augmentent la productivité de 10 à 15 % dans les sols fertiles et peuvent revitaliser les sols dégradés. Leurs produits, Kunza et Kanzama, ont été utilisés sur plus de 800 000 acres au cours de trois saisons commerciales.
L'investissement soutiendra l'expansion du portefeuille de produits et l'entrée sur les marchés des États-Unis, du Brésil et du Paraguay. Le tour de financement inclut la participation des investisseurs existants At One Ventures, SP Ventures, SOSV, Builders VC ainsi que du nouvel investisseur Dalus Capital.
Puna Bio, ein in Argentinien ansässiges Agrartechnologieunternehmen, hat eine neue Finanzierungsrunde unter der Führung von Corteva (NYSE: CTVA) über die Corteva Catalyst-Plattform gesichert. Das Unternehmen spezialisiert sich auf biologische Lösungen mit extremophilen Organismen für regenerative Landwirtschaft.
Die gentechnikfreien Saatgutbehandlungen von Puna Bio, die aus uralten Bakterien aus der argentinischen La Puna-Wüste gewonnen werden, steigern die Produktivität in fruchtbaren Böden um 10-15 % und können degradierte Böden revitalisieren. Ihre Produkte Kunza und Kanzama wurden in drei kommerziellen Saisons auf über 800.000 Acres angewendet.
Die Investition wird die Erweiterung des Produktportfolios und den Markteintritt in die USA, Brasilien und Paraguay unterstützen. An der Finanzierungsrunde beteiligen sich die bestehenden Investoren At One Ventures, SP Ventures, SOSV, Builders VC sowie der neue Investor Dalus Capital.
- Secured new funding from S&P 500 company Corteva (NYSE: CTVA)
- Products demonstrate 10-15% productivity increase in fertile soils
- Commercial products already deployed on 800,000 acres in three seasons
- Expanding into major agricultural markets (US, Brazil, Paraguay)
- Regulatory approvals and commercialization progress in target markets
- None.
Insights
Corteva's strategic investment in Puna Bio strengthens its biological portfolio, targeting sustainable agriculture with extremophile-based solutions showing promising commercial adoption.
Corteva's investment in Puna Bio represents an important strategic expansion into the rapidly growing biological inputs market. These microbe-based products address two critical agricultural challenges: improving productivity in fertile soils and restoring degraded lands affected by acidity or salinity.
What makes Puna Bio's approach unique is their focus on extremophiles—organisms adapted to survive in Earth's harshest environments. These ancient bacteria, dating back 3.5 billion years, have evolved remarkable resilience mechanisms that can be harnessed for agriculture. Their non-GMO biological seed treatments have demonstrated impressive market acceptance, being deployed across 800,000 acres in just three commercial seasons.
The company's current product portfolio includes Kunza (for soybeans, cotton, and beans) and Kanzama (for wheat and barley), with expansion plans for the US, Brazil, and Paraguay markets. This addresses a growing demand for agricultural solutions that reduce chemical inputs while maintaining or improving yields.
This investment aligns perfectly with the agricultural industry's shift toward more sustainable practices. As weather patterns become increasingly unpredictable and soil degradation accelerates globally, biological solutions that enhance crop resilience while promoting soil health will become increasingly valuable. By investing now, Corteva positions itself at the forefront of this agricultural transformation.
Corteva strategically expands its biologicals portfolio through Puna Bio investment, positioning itself in the high-growth sustainable agriculture sector with minimal financial risk.
Corteva's investment in Puna Bio through its Catalyst platform represents a calculated strategic move to strengthen its position in the rapidly expanding biological agricultural inputs market. While the financial terms weren't disclosed, this transaction follows a classic corporate venture capital approach—providing Corteva early access to innovative technology while limiting downside risk.
The investment aligns perfectly with two major agricultural market trends: increasing demand for sustainable farming solutions and growing concerns about soil degradation. By backing Puna Bio's extremophile-based technology, Corteva gains exposure to products claiming 10-15% productivity increases in fertile soils while also addressing degraded land restoration.
From a strategic perspective, this move demonstrates Corteva's hybrid innovation approach—complementing internal R&D with external partnerships. The expansion of Puna Bio into US, Brazil, and Paraguay markets creates potential distribution synergies with Corteva's existing networks in these regions.
For investors, this represents Corteva's continued commitment to diversifying beyond traditional crop protection chemicals and seeds into the biological solutions category. The structure as an investment rather than acquisition suggests a prudent approach—allowing Corteva to participate in Puna Bio's growth trajectory while limiting financial exposure if the technology underperforms expectations.
The investment from one of the world´s leading agricultural technology companies, and other investors, will support the further development of Puna Bio's product portfolio based on extremophile organisms.
Unlike traditional pesticides and fertilizers, Puna Bio's innovative products are based on natural solutions that enhance nutrient uptake, tolerance to stress and crop quality. Their biological (non-GMO) seed treatments are based on the unique capabilities of extremophiles isolated from the highest and driest desert on Earth, La Puna of
"Our solution, based on ancient bacteria dating back 3.5 billion years, maximizes productivity by 10 to 15 percent in fertile soils and revitalizes degraded soils that would normally be too acidic or salinized to be productive," explains Franco Martínez Levis, Puna Bio's CEO and co-founder. "With so much of the world's agricultural land on the path to degradation and weather patterns becoming more extreme worldwide, our discovery platform ensures that we can continue feeding the global population in a sustainable way"
Puna Bio received its initial funding in 2022, led by At One Ventures, a US venture firm with deep roots in Silicon Valley. The capital enabled the establishment of the company's first laboratory and growth of its core team.
The new round of funding led by Corteva, Inc., a global pure-play S&P 500 agriculture company [NYSE: CTVA], as well as participation from existing investors At One Ventures, SP Ventures, SOSV, Builders VC, and joined by new investor Dalus Capital.
"With its focus on new, more sustainable ways to enhance productivity, we see significant potential in Puna Bio and its technology," said Tom Greene, senior director at Corteva and global leader for Corteva Catalyst. "We remain encouraged not only by Puna Bio's unique approach to developing biological inputs, but by strong field results with new technology that presents an opportunity to enhance farmer profitability while promoting soil health and environmental sustainability."
The new investment will enable Puna Bio to focus on deeper innovation and the development of new products. Additionally, the company will expand its business to
About Puna Bio
Puna Bio is advancing agricultural resilience by harnessing extremophiles. Their innovative biological inputs help farmers boost yields, reduce fertilizer use, and grow crops on degraded soils.
With operations across USA,
For more information, please visit www.puna.bio or contact us at info@punabio.com
View original content:https://www.prnewswire.com/news-releases/puna-bio-receives-investment-from-corteva-catalyst-302433659.html
SOURCE Puna Bio
FAQ
What is the productivity increase reported by Puna Bio's biological solutions?
How many acres have Puna Bio's products Kunza and Kanzama been used on?
Which markets is Puna Bio expanding into with the Corteva (CTVA) investment?
What are the main products offered by Puna Bio?
Who are the investors participating in Puna Bio's latest funding round?
